Insider Transactions in Q4 2020 at Edwards Lifesciences Corp (EW)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2020
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
10,722
-1.44%
|
$900,648
$84.5 P/Share
|
|
Dec 15
2020
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
10,722
+2.79%
|
$225,162
$21.76 P/Share
|
|
Dec 14
2020
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
30,000
-9.69%
|
-
|
|
Dec 14
2020
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
30,000
+1.03%
|
-
|
|
Dec 14
2020
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
68,550
-7.84%
|
$5,758,200
$84.89 P/Share
|
|
Dec 14
2020
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
98,550
+24.14%
|
$1,281,150
$13.98 P/Share
|
|
Dec 14
2020
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
11,733
-3.73%
|
$985,572
$84.73 P/Share
|
|
Dec 14
2020
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
11,649
+9.98%
|
$151,437
$13.98 P/Share
|
|
Dec 11
2020
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
13,074
-10.67%
|
$1,111,290
$85.11 P/Share
|
|
Dec 11
2020
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
13,074
+17.51%
|
$169,962
$13.98 P/Share
|
|
Nov 17
2020
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
30,000
+1.04%
|
-
|
|
Nov 17
2020
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
68,550
-6.56%
|
$5,826,750
$85.97 P/Share
|
|
Nov 17
2020
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
30,000
-9.78%
|
-
|
|
Nov 17
2020
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
98,550
+24.14%
|
$1,281,150
$13.98 P/Share
|
|
Nov 16
2020
|
Steven R Loranger Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,797
+29.65%
|
$692,895
$35.2 P/Share
|
|
Nov 13
2020
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
13,074
-10.76%
|
$1,045,920
$80.8 P/Share
|
|
Nov 13
2020
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
13,074
+17.51%
|
$169,962
$13.98 P/Share
|
|
Nov 11
2020
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
11,730
-3.81%
|
$950,130
$81.51 P/Share
|
|
Nov 11
2020
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
11,649
+9.97%
|
$151,437
$13.98 P/Share
|
|
Nov 09
2020
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Indirect |
226
-35.93%
|
$18,758
$83.89 P/Share
|
|
Nov 06
2020
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Indirect |
347
-35.52%
|
$27,066
$78.01 P/Share
|
|
Nov 02
2020
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
10,698
-2.86%
|
$780,954
$73.27 P/Share
|
|
Nov 02
2020
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
10,698
+2.78%
|
$224,658
$21.76 P/Share
|
|
Oct 29
2020
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
20,355
-43.22%
|
$1,485,915
$73.24 P/Share
|
|
Oct 29
2020
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
20,355
+30.18%
|
$447,810
$22.29 P/Share
|
|
Oct 26
2020
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
33,150
-32.3%
|
$2,585,700
$78.73 P/Share
|
|
Oct 26
2020
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,150
+35.49%
|
$696,150
$21.76 P/Share
|
|
Oct 12
2020
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
33,150
-29.86%
|
$2,784,600
$84.03 P/Share
|
|
Oct 12
2020
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,150
+35.49%
|
$696,150
$21.76 P/Share
|
|
Oct 09
2020
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
13,074
-21.23%
|
$1,072,068
$82.61 P/Share
|
|
Oct 09
2020
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
13,074
+17.51%
|
$169,962
$13.98 P/Share
|
|
Oct 09
2020
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
11,733
-5.58%
|
$962,106
$82.39 P/Share
|
|
Oct 09
2020
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
11,649
+9.96%
|
$151,437
$13.98 P/Share
|
|
Oct 09
2020
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
30,000
+1.05%
|
-
|
|
Oct 09
2020
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
30,000
-12.44%
|
-
|
|
Oct 09
2020
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
68,550
-11.69%
|
$5,689,650
$83.05 P/Share
|
|
Oct 09
2020
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
98,550
+24.14%
|
$1,281,150
$13.98 P/Share
|
|
Oct 01
2020
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
10,698
-2.86%
|
$855,840
$80.38 P/Share
|
|
Oct 01
2020
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
10,698
+2.78%
|
$224,658
$21.76 P/Share
|